Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Bronchodilator reversibility in asthma and COPD: Findings from three large population studies.

Janson C, Malinovschi A, Amaral AFS, Accordini S, Bousquet J, Sonia Buist A, Canonica GW, Dahlén B, Garcia-Aymerich J, Gnatiuc L, Kowalski ML, Patel J, Tan W, Torén K, Zuberbier T, Burney P, Jarvis D.

Eur Respir J. 2019 Jun 20. pii: 1900561. doi: 10.1183/13993003.00561-2019. [Epub ahead of print]

PMID:
31221806
2.

Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux.

Perotin JM, Schofield JPR, Wilson SJ, Ward J, Brandsma J, Strazzeri F, Bansal A, Yang X, Rowe A, Corfield J, Lutter R, Shaw DE, Bakke PS, Caruso M, Dahlén B, Fowler SJ, Horváth I, Howarth P, Krug N, Montuschi P, Sanak M, Sandström T, Sun K, Pandis I, Auffray C, De Meulder B, Lefaudeux D, Riley JH, Sousa AR, Dahlen SE, Adcock IM, Chung KF, Sterk PJ, Skipp PJ, Collins JE, Davies DE, Djukanović R; U-BIOPRED Study Group; U-BIOPRED:.

Eur Respir J. 2019 Jun 27;53(6). pii: 1900453. doi: 10.1183/13993003.00453-2019. Print 2019 Jun. No abstract available.

PMID:
31023846
3.

Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma.

Tariq K, Schofield JPR, Nicholas BL, Burg D, Brandsma J, Bansal AT, Wilson SJ, Lutter R, Fowler SJ, Bakke, Caruso M, Dahlen B, Horváth I, Krug N, Montuschi P, Sanak M, Sandström T, Geiser T, Pandis I, Sousa AR, Adcock IM, Shaw DE, Auffray C, Howarth PH, Sterk PJ, Chung KF, Skipp PJ, Dimitrov B, Djukanović R; U-BIOPRED Study Group.

Respir Med. 2019 Apr;150:66-73. doi: 10.1016/j.rmed.2019.02.008. Epub 2019 Feb 11.

PMID:
30961953
4.

Contribution of airway eosinophils in airway wall remodeling in asthma: Role of MMP-10 and MET.

Kuo CS, Pavlidis S, Zhu J, Loza M, Baribaud F, Rowe A, Pandis I, Gibeon D, Hoda U, Sousa A, Wilson SJ, Howarth P, Shaw D, Fowler S, Dahlen B, Chanez P, Krug N, Sandstrom T, Fleming L, Corfield J, Auffray C, Djukanovic R, Sterk PJ, Guo Y, Adcock IM, Chung KF; U-BIOPRED Project Team.

Allergy. 2019 Jun;74(6):1102-1112. doi: 10.1111/all.13727. Epub 2019 Feb 11.

PMID:
30667542
5.

Treatable traits in the European U-BIOPRED adult asthma cohorts.

Simpson AJ, Hekking PP, Shaw DE, Fleming LJ, Roberts G, Riley JH, Bates S, Sousa AR, Bansal AT, Pandis I, Sun K, Bakke PS, Caruso M, Dahlén B, Dahlén SE, Horvath I, Krug N, Montuschi P, Sandstrom T, Singer F, Adcock IM, Wagers SS, Djukanovic R, Chung KF, Sterk PJ, Fowler SJ; U-BIOPRED Study Group.

Allergy. 2019 Feb;74(2):406-411. doi: 10.1111/all.13629. Epub 2018 Nov 12. No abstract available.

6.

Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort.

Emma R, Bansal AT, Kolmert J, Wheelock CE, Dahlen SE, Loza MJ, De Meulder B, Lefaudeux D, Auffray C, Dahlen B, Bakke PS, Chanez P, Fowler SJ, Horvath I, Montuschi P, Krug N, Sanak M, Sandstrom T, Shaw DE, Fleming LJ, Djukanovic R, Howarth PH, Singer F, Sousa AR, Sterk PJ, Corfield J, Pandis I, Chung KF, Adcock IM, Lutter R, Fabbella L, Caruso M; U-BIOPRED Study Group.

PLoS One. 2018 Sep 21;13(9):e0203874. doi: 10.1371/journal.pone.0203874. eCollection 2018.

7.

Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation.

Jevnikar Z, Östling J, Ax E, Calvén J, Thörn K, Israelsson E, Öberg L, Singhania A, Lau LCK, Wilson SJ, Ward JA, Chauhan A, Sousa AR, De Meulder B, Loza MJ, Baribaud F, Sterk PJ, Chung KF, Sun K, Guo Y, Adcock IM, Payne D, Dahlen B, Chanez P, Shaw DE, Krug N, Hohlfeld JM, Sandström T, Djukanovic R, James A, Hinks TSC, Howarth PH, Vaarala O, van Geest M, Olsson H; Unbiased Biomarkers in Prediction of Respiratory Disease Outcomes study group.

J Allergy Clin Immunol. 2019 Feb;143(2):577-590. doi: 10.1016/j.jaci.2018.05.026. Epub 2018 Jun 11.

8.

Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis.

Takahashi K, Pavlidis S, Ng Kee Kwong F, Hoda U, Rossios C, Sun K, Loza M, Baribaud F, Chanez P, Fowler SJ, Horvath I, Montuschi P, Singer F, Musial J, Dahlen B, Dahlen SE, Krug N, Sandstrom T, Shaw DE, Lutter R, Bakke P, Fleming LJ, Howarth PH, Caruso M, Sousa AR, Corfield J, Auffray C, De Meulder B, Lefaudeux D, Djukanovic R, Sterk PJ, Guo Y, Adcock IM, Chung KF; , on behalf of the U-BIOPRED study group.

Eur Respir J. 2018 May 3;51(5). pii: 1702173. doi: 10.1183/13993003.02173-2017. Print 2018 May.

PMID:
29650557
9.

Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults.

Porsbjerg C, Ulrik C, Skjold T, Backer V, Laerum B, Lehman S, Janson C, Sandstrøm T, Bjermer L, Dahlen B, Lundbäck B, Ludviksdottir D, Björnsdóttir U, Altraja A, Lehtimäki L, Kauppi P, Karjalainen J, Kankaanranta H.

Eur Clin Respir J. 2018 Mar 6;5(1):1440868. doi: 10.1080/20018525.2018.1440868. eCollection 2018. Review.

10.

Leukotriene E4 induces airflow obstruction and mast cell activation through the cysteinyl leukotriene type 1 receptor.

Lazarinis N, Bood J, Gomez C, Kolmert J, Lantz AS, Gyllfors P, Davis A, Wheelock CE, Dahlén SE, Dahlén B.

J Allergy Clin Immunol. 2018 Oct;142(4):1080-1089. doi: 10.1016/j.jaci.2018.02.024. Epub 2018 Mar 5.

PMID:
29518425
11.

RNA-containing exosomes in induced sputum of asthmatic patients.

Sánchez-Vidaurre S, Eldh M, Larssen P, Daham K, Martinez-Bravo MJ, Dahlén SE, Dahlén B, van Hage M, Gabrielsson S.

J Allergy Clin Immunol. 2017 Nov;140(5):1459-1461.e2. doi: 10.1016/j.jaci.2017.05.035. Epub 2017 Jun 16. No abstract available.

PMID:
28629752
12.

Upper airway and skin symptoms in allergic and non-allergic asthma: Results from the Swedish GA2LEN study.

Kämpe M, Vosough M, Malinovschi A, Alimohammadi M, Alving K, Forsberg B, Lötvall J, Middelveld R, Dahlén B, Janson C.

J Asthma. 2018 Mar;55(3):275-283. doi: 10.1080/02770903.2017.1326132. Epub 2017 May 26.

PMID:
28463525
13.

Serum periostin relates to type-2 inflammation and lung function in asthma: Data from the large population-based cohort Swedish GA(2)LEN.

James A, Janson C, Malinovschi A, Holweg C, Alving K, Ono J, Ohta S, Ek A, Middelveld R, Dahlén B, Forsberg B, Izuhara K, Dahlén SE.

Allergy. 2017 Nov;72(11):1753-1760. doi: 10.1111/all.13181. Epub 2017 May 22.

PMID:
28398635
14.

Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis.

Gülen T, Möller Westerberg C, Lyberg K, Ekoff M, Kolmert J, Bood J, Öhd J, James A, Dahlén SE, Nilsson G, Dahlén B.

Clin Exp Allergy. 2017 Jul;47(7):909-917. doi: 10.1111/cea.12914. Epub 2017 Apr 4.

PMID:
28258965
15.

Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study.

Wilson SJ, Ward JA, Sousa AR, Corfield J, Bansal AT, De Meulder B, Lefaudeux D, Auffray C, Loza MJ, Baribaud F, Fitch N, Sterk PJ, Chung KF, Gibeon D, Sun K, Guo YK, Adcock I, Djukanovic R, Dahlen B, Chanez P, Shaw D, Krug N, Hohlfeld J, Sandström T, Howarth PH; U-BIOPRED Study Group.

Eur Respir J. 2016 Nov;48(5):1307-1319. doi: 10.1183/13993003.01129-2016. Epub 2016 Oct 6.

16.

Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69-CD56dim cells.

Marquardt N, Kekäläinen E, Chen P, Kvedaraite E, Wilson JN, Ivarsson MA, Mjösberg J, Berglin L, Säfholm J, Manson ML, Adner M, Al-Ameri M, Bergman P, Orre AC, Svensson M, Dahlén B, Dahlén SE, Ljunggren HG, Michaëlsson J.

J Allergy Clin Immunol. 2017 Apr;139(4):1321-1330.e4. doi: 10.1016/j.jaci.2016.07.043. Epub 2016 Sep 23.

PMID:
27670241
17.

Impact of tobacco smoking on cytokine signaling via interleukin-17A in the peripheral airways.

Levänen B, Glader P, Dahlén B, Billing B, Qvarfordt I, Palmberg L, Larsson K, Lindén A.

Int J Chron Obstruct Pulmon Dis. 2016 Sep 6;11:2109-2116. eCollection 2016.

18.

A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED.

Kuo CS, Pavlidis S, Loza M, Baribaud F, Rowe A, Pandis I, Hoda U, Rossios C, Sousa A, Wilson SJ, Howarth P, Dahlen B, Dahlen SE, Chanez P, Shaw D, Krug N, Sandstrӧm T, De Meulder B, Lefaudeux D, Fowler S, Fleming L, Corfield J, Auffray C, Sterk PJ, Djukanovic R, Guo Y, Adcock IM, Chung KF; U-BIOPRED Project Team ‡ .

Am J Respir Crit Care Med. 2017 Feb 15;195(4):443-455. doi: 10.1164/rccm.201512-2452OC.

19.

Selective COX-2 Inhibition Exerts No Negative Effects on Peripheral Blood Lymphocytes in Allergic Asthmatics.

Gafvelin G, Grundström J, Edin Grimheden M, Sánchez Vidaurre S, Daham K, Dahlén SE, Dahlén B, van Hage M.

Int Arch Allergy Immunol. 2016;170(1):57-61. doi: 10.1159/000446960. Epub 2016 Jul 2.

20.

Effects of budesonide on toll-like receptor expression in alveolar macrophages from smokers with and without COPD.

Ji J, von Schéele I, Billing B, Dahlén B, Lantz AS, Larsson K, Palmberg L.

Int J Chron Obstruct Pulmon Dis. 2016 May 17;11:1035-43. doi: 10.2147/COPD.S102668. eCollection 2016.

21.

Respiratory hypersensitivity reactions to NSAIDs in Europe: the global allergy and asthma network (GA2 LEN) survey.

Makowska JS, Burney P, Jarvis D, Keil T, Tomassen P, Bislimovska J, Brozek G, Bachert C, Baelum J, Bindslev-Jensen C, Bousquet J, Bousquet PJ, Kai-Håkon C, Dahlen SE, Dahlen B, Fokkens WJ, Forsberg B, Gjomarkaj M, Howarth P, Salagean E, Janson C, Kasper L, Kraemer U, Louiro C, Lundback B, Minov J, Nizankowska-Mogilnicka E, Papadopoulos N, Sakellariou AG, Todo-Bom A, Toskala E, Zejda JE, Zuberbier T, Kowalski ML.

Allergy. 2016 Nov;71(11):1603-1611. doi: 10.1111/all.12941. Epub 2016 Jul 11.

PMID:
27230252
22.

Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses.

Gauvreau GM, Arm JP, Boulet LP, Leigh R, Cockcroft DW, Davis BE, Mayers I, FitzGerald JM, Dahlen B, Killian KJ, Laviolette M, Carlsten C, Lazarinis N, Watson RM, Milot J, Swystun V, Bowen M, Hui L, Lantz AS, Meiser K, Maahs S, Lowe PJ, Skerjanec A, Drollmann A, O'Byrne PM.

J Allergy Clin Immunol. 2016 Oct;138(4):1051-1059. doi: 10.1016/j.jaci.2016.02.027. Epub 2016 Apr 7.

PMID:
27185571
23.

Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD.

Balgoma D, Yang M, Sjödin M, Snowden S, Karimi R, Levänen B, Merikallio H, Kaarteenaho R, Palmberg L, Larsson K, Erle DJ, Dahlén SE, Dahlén B, Sköld CM, Wheelock ÅM, Wheelock CE.

Eur Respir J. 2016 Jun;47(6):1645-56. doi: 10.1183/13993003.01080-2015. Epub 2016 Mar 10.

24.

A standard, single dose of inhaled terbutaline attenuates hyperpnea-induced bronchoconstriction and mast cell activation in athletes.

Simpson AJ, Bood JR, Anderson SD, Romer LM, Dahlén B, Dahlén SE, Kippelen P.

J Appl Physiol (1985). 2016 May 1;120(9):1011-7. doi: 10.1152/japplphysiol.00700.2015. Epub 2016 Feb 4.

25.

Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.

James AJ, Reinius LE, Verhoek M, Gomes A, Kupczyk M, Hammar U, Ono J, Ohta S, Izuhara K, Bel E, Kere J, Söderhäll C, Dahlén B, Boot RG, Dahlén SE; BIOAIR (Longitudinal Assessment of Clinical Course and Biomarkers in Severe Chronic Airway Disease) Consortium.

Am J Respir Crit Care Med. 2016 Jan 15;193(2):131-42. doi: 10.1164/rccm.201504-0760OC.

PMID:
26372680
26.

Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort.

Shaw DE, Sousa AR, Fowler SJ, Fleming LJ, Roberts G, Corfield J, Pandis I, Bansal AT, Bel EH, Auffray C, Compton CH, Bisgaard H, Bucchioni E, Caruso M, Chanez P, Dahlén B, Dahlen SE, Dyson K, Frey U, Geiser T, Gerhardsson de Verdier M, Gibeon D, Guo YK, Hashimoto S, Hedlin G, Jeyasingham E, Hekking PP, Higenbottam T, Horváth I, Knox AJ, Krug N, Erpenbeck VJ, Larsson LX, Lazarinis N, Matthews JG, Middelveld R, Montuschi P, Musial J, Myles D, Pahus L, Sandström T, Seibold W, Singer F, Strandberg K, Vestbo J, Vissing N, von Garnier C, Adcock IM, Wagers S, Rowe A, Howarth P, Wagener AH, Djukanovic R, Sterk PJ, Chung KF; U-BIOPRED Study Group.

Eur Respir J. 2015 Nov;46(5):1308-21. doi: 10.1183/13993003.00779-2015. Epub 2015 Sep 10. Erratum in: Eur Respir J. 2017 Jun 22;49(6):.

27.

Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.

Gülen T, Hägglund H, Dahlén B, Nilsson G.

J Intern Med. 2016 Mar;279(3):211-28. doi: 10.1111/joim.12410. Epub 2015 Sep 8. Review.

28.

Urinary excretion of lipid mediators in response to repeated eucapnic voluntary hyperpnea in asthmatic subjects.

Bood JR, Sundblad BM, Delin I, Sjödin M, Larsson K, Anderson SD, Wheelock CE, Dahlén SE, Dahlén B.

J Appl Physiol (1985). 2015 Aug 1;119(3):272-9. doi: 10.1152/japplphysiol.00301.2015. Epub 2015 Jun 25.

29.

On the biosynthesis of 15-HETE and eoxin C4 by human airway epithelial cells.

Brunnström Å, Tryselius Y, Feltenmark S, Andersson E, Leksell H, James A, Mannervik B, Dahlén B, Claesson HE.

Prostaglandins Other Lipid Mediat. 2015 Sep;121(Pt A):83-90. doi: 10.1016/j.prostaglandins.2015.04.010. Epub 2015 May 27.

PMID:
26026713
30.

The effect of omega-3 fatty acids on bronchial hyperresponsiveness, sputum eosinophilia, and mast cell mediators in asthma.

Brannan JD, Bood J, Alkhabaz A, Balgoma D, Otis J, Delin I, Dahlén B, Wheelock CE, Nair P, Dahlén SE, O'Byrne PM.

Chest. 2015 Feb;147(2):397-405. doi: 10.1378/chest.14-1214.

31.

Compartment differences of inflammatory activity in chronic obstructive pulmonary disease.

Ji J, von Schéele I, Bergström J, Billing B, Dahlén B, Lantz AS, Larsson K, Palmberg L.

Respir Res. 2014 Aug 26;15:104. doi: 10.1186/s12931-014-0104-3.

32.

The presence of mast cell clonality in patients with unexplained anaphylaxis.

Gülen T, Hägglund H, Sander B, Dahlén B, Nilsson G.

Clin Exp Allergy. 2014 Sep;44(9):1179-87. doi: 10.1111/cea.12369.

PMID:
25039926
33.

Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma.

Kupczyk M, Dahlén B, Sterk PJ, Nizankowska-Mogilnicka E, Papi A, Bel EH, Chanez P, Howarth PH, Holgate ST, Brusselle G, Siafakas NM, Gjomarkaj M, Dahlén SE; BIOAIR investigators.

Allergy. 2014 Sep;69(9):1198-204. doi: 10.1111/all.12445. Epub 2014 Jul 8.

PMID:
25039610
34.

Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production.

Gauvreau GM, Harris JM, Boulet LP, Scheerens H, Fitzgerald JM, Putnam WS, Cockcroft DW, Davis BE, Leigh R, Zheng Y, Dahlén B, Wang Y, Maciuca R, Mayers I, Liao XC, Wu LC, Matthews JG, O'Byrne PM.

Sci Transl Med. 2014 Jul 2;6(243):243ra85. doi: 10.1126/scitranslmed.3008961.

35.

Interleukin-17 cytokine signalling in patients with asthma.

Lindén A, Dahlén B.

Eur Respir J. 2014 Nov;44(5):1319-31. doi: 10.1183/09031936.00002314. Epub 2014 Jun 12. Review.

36.

Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis.

Gülen T, Hägglund H, Dahlén SE, Sander B, Dahlén B, Nilsson G.

Lancet. 2014 May 3;383(9928):1608. doi: 10.1016/S0140-6736(14)60585-7. No abstract available.

PMID:
24792857
37.

Bitter taste receptor (TAS2R) agonists inhibit IgE-dependent mast cell activation.

Ekoff M, Choi JH, James A, Dahlén B, Nilsson G, Dahlén SE.

J Allergy Clin Immunol. 2014 Aug;134(2):475-8. doi: 10.1016/j.jaci.2014.02.029. Epub 2014 Apr 19. No abstract available.

PMID:
24755408
38.

Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma.

Daham K, James A, Balgoma D, Kupczyk M, Billing B, Lindeberg A, Henriksson E, FitzGerald GA, Wheelock CE, Dahlén SE, Dahlén B.

J Allergy Clin Immunol. 2014 Aug;134(2):306-13. doi: 10.1016/j.jaci.2013.12.002. Epub 2014 Jan 22.

PMID:
24461582
39.

Frequent exacerbators--a distinct phenotype of severe asthma.

Kupczyk M, ten Brinke A, Sterk PJ, Bel EH, Papi A, Chanez P, Nizankowska-Mogilnicka E, Gjomarkaj M, Gaga M, Brusselle G, Dahlén B, Dahlén SE; BIOAIR investigators.

Clin Exp Allergy. 2014 Feb;44(2):212-21. doi: 10.1111/cea.12179.

PMID:
24447083
40.

Enhanced expression of neuropeptide S (NPS) receptor in eosinophils from severe asthmatics and subjects with total IgE above 100IU/ml.

Ilmarinen P, James A, Moilanen E, Pulkkinen V, Daham K, Saarelainen S, Laitinen T, Dahlén SE, Kere J, Dahlén B, Kankaanranta H.

Peptides. 2014 Jan;51:100-9. doi: 10.1016/j.peptides.2013.10.030. Epub 2013 Nov 13.

PMID:
24239856
41.

High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.

Gülen T, Hägglund H, Dahlén B, Nilsson G.

Clin Exp Allergy. 2014 Jan;44(1):121-9. doi: 10.1111/cea.12225.

PMID:
24164252
42.

Inhaled allergen bronchoprovocation tests.

Diamant Z, Gauvreau GM, Cockcroft DW, Boulet LP, Sterk PJ, de Jongh FH, Dahlén B, O'Byrne PM.

J Allergy Clin Immunol. 2013 Nov;132(5):1045-1055.e6. doi: 10.1016/j.jaci.2013.08.023. Epub 2013 Oct 11. Review.

PMID:
24119772
43.

Combination of budesonide/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction.

Lazarinis N, Jørgensen L, Ekström T, Bjermer L, Dahlén B, Pullerits T, Hedlin G, Carlsen KH, Larsson K.

Thorax. 2014 Feb;69(2):130-6. doi: 10.1136/thoraxjnl-2013-203557. Epub 2013 Oct 3.

44.

Phenotypic predictors of response to oral glucocorticosteroids in severe asthma.

Kupczyk M, Haque S, Middelveld RJ, Dahlén B, Dahlén SE; BIOAIR Investigators.

Respir Med. 2013 Oct;107(10):1521-30. doi: 10.1016/j.rmed.2013.07.014. Epub 2013 Aug 27.

45.

The influence of aspirin on release of eoxin C4, leukotriene C4 and 15-HETE, in eosinophilic granulocytes isolated from patients with asthma.

James A, Daham K, Backman L, Brunnström A, Tingvall T, Kumlin M, Edenius C, Dahlén SE, Dahlén B, Claesson HE.

Int Arch Allergy Immunol. 2013;162(2):135-42. doi: 10.1159/000351422. Epub 2013 Jul 31.

PMID:
23921438
46.

Quantification of lipid mediator metabolites in human urine from asthma patients by electrospray ionization mass spectrometry: controlling matrix effects.

Balgoma D, Larsson J, Rokach J, Lawson JA, Daham K, Dahlén B, Dahlén SE, Wheelock CE.

Anal Chem. 2013 Aug 20;85(16):7866-74. doi: 10.1021/ac401461b. Epub 2013 Aug 7.

PMID:
23863083
47.

Refractoriness to exercise challenge: a review of the mechanisms old and new.

Larsson J, Anderson SD, Dahlén SE, Dahlén B.

Immunol Allergy Clin North Am. 2013 Aug;33(3):329-45, viii. doi: 10.1016/j.iac.2013.02.004. Epub 2013 Mar 27. Review.

PMID:
23830128
48.

The significance of diagnosing associated clonal mast cell diseases in patients with venom-induced anaphylaxis and the role of bone marrow investigation.

Gülen T, Dahlén B, Sander B, Hägglund H, Nilsson G.

Clin Transl Allergy. 2013 Jul 4;3(1):22. doi: 10.1186/2045-7022-3-22.

49.

Adhesion molecules in subjects with COPD and healthy non-smokers: a cross sectional parallel group study.

Blidberg K, Palmberg L, James A, Billing B, Henriksson E, Lantz AS, Larsson K, Dahlén B.

Respir Res. 2013 May 1;14:47. doi: 10.1186/1465-9921-14-47.

50.

The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma.

Konradsen JR, James A, Nordlund B, Reinius LE, Söderhäll C, Melén E, Wheelock AM, Lödrup Carlsen KC, Lidegran M, Verhoek M, Boot RG, Dahlén B, Dahlén SE, Hedlin G.

J Allergy Clin Immunol. 2013 Aug;132(2):328-35.e5. doi: 10.1016/j.jaci.2013.03.003. Epub 2013 Apr 26. Erratum in: J Allergy Clin Immunol. 2013 Nov;132(5):1259. Wheelock, Asa [corrected to Wheelock, Asa M].

PMID:
23628340

Supplemental Content

Loading ...
Support Center